✦ LIBER ✦

Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy

✍ Scribed by Divi Cornec; Adrian Tempescul; Solène Querellou; Pascal Hutin; Jacques-Olivier Pers; Christophe Jamin; Boutahar Bendaoud; Christian Berthou; Yves Renaudineau; Pierre Youinou

Book ID: 111682663
Publisher: Springer
Year: 2011
Tongue: English
Weight: 142 KB
Volume: 91
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1369-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re-Treatment of Relapsed Indolent B-Cell

Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab

✍ Tadahiko Igarashi; Tomoko Ohtsu; Hirofumi Fujii; Yasutsuna Sasaki; Yasuo Morishi 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 117 KB

Rituximab monotherapy with eight weekly

Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: A multicenter phase II study

✍ Kensei Tobinai; Tadahiko Igarashi; Kuniaki Itoh; Mitsutoshi Kurosawa; Hirokazu N 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Bendamustine is effective therapy in pat

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma : Results from a Multicenter Study

✍ Brad S. Kahl; Nancy L. Bartlett; John P. Leonard; Ling Chen; Kristen Ganjoo; Mic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Bendamustine and Rituximab for Indolent

Bendamustine and Rituximab for Indolent B-Cell Non-Hodgkin Lymphoma in Patients With Compensated Hepatitis C Cirrhosis: A Case Series

✍ Parker, Stacey M.; Hyder, Mustafa A.; Fesler, Mark J. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 92 KB

Rituximab appears to be beneficial in pa

Rituximab appears to be beneficial in patients with primary cutaneous B-cell lymphoma,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB